Saturday , October 21 2017
Home / Resources / Clinical Presentations / GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 3 of 4

GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 3 of 4

This week, we present Part 3 of a series of 4 Homerun Slide collections covering GLP-1 Agonist therapy. This week’s slides present findings on the therapeutic effects of GLP-1, GLP-1 agonists and DPP-IV inhibitors (which increase circulating levels of endogenous active GLP-1 and GIP) in patients with T2DM….

Link to download (.ppt format): GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 3 of 4

Other sets in this series:

GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 1 of 4
GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 2 of 4
GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 3 of 4
GLP-1 Effectiveness, Mechanisms of Action and Potential, Part 4 of 4

See more GLP-1 Agonist Resources.